07.05.2012 - Swiss drugmaker Roche has ended efforts to develop a heart disease drug which some industry analysts had estimated could have achieved $10 billion in annual sales, after poor...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)